close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

915.16

+1.7%↑

JNJ

240.9

+2.79%↑

ABBV

208.4

+1.29%↑

NVS

151.5

+2.18%↑

MRK

119.53

+3.27%↑

LLY

915.16

+1.7%↑

JNJ

240.9

+2.79%↑

ABBV

208.4

+1.29%↑

NVS

151.5

+2.18%↑

MRK

119.53

+3.27%↑

LLY

915.16

+1.7%↑

JNJ

240.9

+2.79%↑

ABBV

208.4

+1.29%↑

NVS

151.5

+2.18%↑

MRK

119.53

+3.27%↑

LLY

915.16

+1.7%↑

JNJ

240.9

+2.79%↑

ABBV

208.4

+1.29%↑

NVS

151.5

+2.18%↑

MRK

119.53

+3.27%↑

LLY

915.16

+1.7%↑

JNJ

240.9

+2.79%↑

ABBV

208.4

+1.29%↑

NVS

151.5

+2.18%↑

MRK

119.53

+3.27%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorHealthcare

5.37 -6.28

Strong Buy

Price update 25 mar 2026, 14:45 UTC

BuySell

Overview

Share price change

24h

Current

Min

5.15

Max

5.8

Key metrics

By Trading Economics

Income

-69M

-102M

Sales

-10M

34M

EPS

-5.69

Profit margin

-299.886

Employees

228

EBITDA

4.7M

-18M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+258.46% upside

Market Stats

By TradingEconomics

Market Cap

-35M

122M

Previous open

11.65

Previous close

5.37

News Sentiment

By Acuity

36%

64%

119 / 350 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 mar 2026, 18:58 UTC

Major Market Movers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

DJ

Read

24 mar 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

24 mar 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

DJ

Read

24 mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Rises, Boosted by Dollar Weakness -- Market Talk

DJ

Read

24 mar 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

DJ

Read

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

DJ

Read

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

DJ

Read

24 mar 2026, 22:40 UTC

Earnings

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

DJ

Read

24 mar 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

24 mar 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

DJ

Read

24 mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

DJ

Read

24 mar 2026, 20:58 UTC

Major News Events

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

DJ

Read

24 mar 2026, 20:50 UTC

Market Talk
Major News Events

Energy & Utilities Roundup: Market Talk

DJ

Read

24 mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

24 mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

24 mar 2026, 20:25 UTC

Earnings

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

DJ

Read

24 mar 2026, 20:15 UTC

Market Talk
Major News Events

Global Commodities Roundup: Market Talk

DJ

Read

24 mar 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

DJ

Read

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Sales $378.7M >WOR

DJ

Read

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q Adj EPS 98c >WOR

DJ

Read

24 mar 2026, 20:10 UTC

Earnings

Worthington Enterprises 3Q EPS 92c >WOR

DJ

Read

24 mar 2026, 19:25 UTC

Market Talk
Major News Events

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

DJ

Read

24 mar 2026, 19:06 UTC

Market Talk
Major News Events

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

DJ

Read

24 mar 2026, 18:51 UTC

Market Talk
Major News Events

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

DJ

Read

24 mar 2026, 18:40 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

24 mar 2026, 18:40 UTC

Market Talk
Major News Events

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

DJ

Read

24 mar 2026, 18:34 UTC

Major News Events

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

DJ

Read

24 mar 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

DJ

Read

24 mar 2026, 18:21 UTC

Market Talk
Major News Events

Silver Snaps 9-Session Losing Streak -- Market Talk

DJ

Read

24 mar 2026, 18:00 UTC

Acquisitions, Mergers, Takeovers

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

258.46% upside

12 Months Forecast

Average 19.5 USD  258.46%

High 28 USD

Low 12 USD

Based on 5 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Based on 5 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

119 / 350 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

915.16

↑ +1.7%

JNJ

Johnson and Johnson

240.9

↑ +2.79%

ABBV

AbbVie Inc

208.4

↑ +1.29%

NVS

Novartis AG

151.5

↑ +2.18%

MRK

Merck & Co Inc.

119.53

↑ +3.27%
help-icon Live chat